secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulcrum Therapeutics, Inc. (FULC)
CIK:        0001680581
Form:       8-K
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001193125-24-205347
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulcrum Therapeutics exchanges 9.35M shares for pre-funded warrants with RA Capital and another stockholder
--------------------------------------------------------------------------------

- RA Capital exchanged 8,500,000 shares for a pre-funded warrant for 8,500,000 shares at $0.001 exercise price, no expiration.
- Another institutional stockholder exchanged 850,000 shares for pre-funded warrants for 850,000 shares on same terms.
- Beneficial ownership blocker set at 9.99%; RA Capital can increase to 19.99% with 61 days' notice.
- No cash proceeds to Fulcrum; exchange exempt from registration under Section 3(a)(9) of the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680581/000119312524205347/0001193125-24-205347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680581/000119312524205347/d98656d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-205347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer